Thursday, September 3, 2009

Pfourth Pfizer Pfine

Pfizer has been fined $2.3 bn for illegally marketing its arthritis and menstrual pain relief drug Bextra for untested, off-prescription purposes.

This is Pfizer's 4th such fine. For this recidivism, $2.3 bn amounts to about three weeks of Pfizer pharmaceutical sales.

Doesn't Pfizer have a drug for learning impairment?

I have to wonder at a pain medicine that covers pre-menopausal and probably post-menopausal women. I'd like to see the clinical trial results for Bextra, and will do some research on that next.

What about heart medications given to women that have not been tested on women? Recent studies of metoprolol tartrate indicate gender-specific differences. Metoprolol was introduced in 1982 with no women included in clinical trials, yet the drug is widely prescribed to women.

The Agency for Healthcare Research and Quality a unit of the U.S. Department of Health and Human Services, now directed by Secretary Kathleen Sebelius, has studies available for free regarding medical conditions and study findings on a wide array of health topics. Use the resource. You are your medical team leader. Keep informed.

Society for Women's Health Rsearch is working for good health care for women. Yes, there are some decent health care lobbyists.

Good on ya! Justice and Health and Human Services Departments!

No comments:

Post a Comment